PRGO Stock Risk & Deep Value Analysis
Perrigo Company PLC
DVR Score
out of 10
What You Need to Know About PRGO Stock
We analyzed Perrigo Company PLC using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran PRGO through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.
How Risky Is PRGO Stock?
Overall Risk
Moderate
Financial Risk
Medium
Market Risk
Medium
Competitive Risk
High
Execution Risk
Medium
Regulatory Risk
Medium
What Are the Red Flags for PRGO?
- ⚠
Intensified competition from large pharmaceutical or consumer goods companies
- ⚠
Supply chain disruptions impacting product availability and cost
- ⚠
Unfavorable regulatory changes affecting OTC drug approvals or marketing
- ⚠
Higher-than-expected interest rates impacting debt servicing
Unlock PRGO Red Flags & Risk Warnings
Create a free account to see the full analysis
Is PRGO Stock Undervalued?
Unlock the full AI analysis for PRGO
Get the complete DVR score, risk analysis, and more
Does PRGO Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Stable
Moat Sources
3 Identified
Perrigo's moat is durable due to established brand loyalty for its store brands and select OTC products, cost advantages from scale and efficient manufacturing, and regulatory expertise which acts as a barrier to entry. This provides stability within its market niches.
Moat Erosion Risks
- •Increasing competitive pressure from larger, better-funded consumer health players
- •Erosion of private label market share due to aggressive branded marketing
- •Disruptive innovation from smaller, agile startups in niche health segments
PRGO Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive PRGO Stock Higher?
Near-Term (0-6 months)
- •Q1 2026 Earnings Report (Estimated Late April / Early May 2026)
- •Continued progress on debt reduction initiatives
- •Launch of new store-brand or Rx-to-OTC switch products
Medium-Term (6-18 months)
- •Further portfolio rationalization and non-core asset sales
- •Potential strategic partnerships in specific consumer health categories
- •Market share gains in key self-care categories (incremental)
Long-Term (18+ months)
- •Benefiting from aging demographics and increased self-care trends
- •Sustained cash flow generation supporting dividend and share repurchases
- •Long-term stability in the consumer health sector
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for PRGO?
- ✓
Sustained acceleration in organic net sales growth beyond low single digits
- ✓
Significant improvements in adjusted operating margins
- ✓
Faster-than-expected reduction in net debt and strong free cash flow conversion
Bull Case Analysis
See what could go right with Premium
Compare PRGO to Similar Stocks
See how Perrigo Company PLC stacks up against related companies in our head-to-head analysis.
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for PRGO (Perrigo Company PLC) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.
